Islam Hassan
About
Islam Hassan is a scholar working on Genetics, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Islam Hassan has authored 37 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 19 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Islam Hassan's work include Glioma Diagnosis and Treatment (24 papers), Radiomics and Machine Learning in Medical Imaging (18 papers) and MRI in cancer diagnosis (5 papers). Islam Hassan is often cited by papers focused on Glioma Diagnosis and Treatment (24 papers), Radiomics and Machine Learning in Medical Imaging (18 papers) and MRI in cancer diagnosis (5 papers). Islam Hassan collaborates with scholars based in United States, France and Switzerland. Islam Hassan's co-authors include Rivka R. Colen, Pascal O. Zinn, Aikaterini Kotrotsou, Nabil Elshafeey, Gregory N. Fuller, Srishti Abrol, Ginu Thomas, Sanjay K. Singh, Patrick Y. Wen and Shuchi S. Pandya and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.
In The Last Decade
Islam Hassan
35 papers receiving 541 citations
Hit Papers
Peers
Islam Hassan
Bethania Fernandes Italy
Abudumijiti Aibaidula China
Jan‐Michael Werner Germany
Mart A. A. M. Heesters Netherlands
Thomas Urup Denmark
Baoshi Chen China
Kirsten Grunnet Denmark
Annekathrin Kratz Germany
Marta Padovan Italy
Christine Jungk Germany
Citations per year, relative to Islam Hassan Islam Hassan (= 1×)
peers
Bethania Fernandes
Countries citing papers authored by Islam Hassan
Since
Specialization
Citations
This map shows the geographic impact of Islam Hassan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Islam Hassan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Islam Hassan more than expected).
Fields of papers citing papers by Islam Hassan
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Islam Hassan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Islam Hassan. The network helps show where Islam Hassan may publish in the future.
Co-authorship network of co-authors of Islam Hassan
This figure shows the co-authorship network connecting the top 25 collaborators of Islam Hassan. A scholar is included among the top collaborators of Islam Hassan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Islam Hassan. Islam Hassan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bent, Martin J. van den, Ingo K. Mellinghoff, Mehdi Touat, et al.. (2024). 10311- ACT-19 A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMA WITH AN IDH1/2 MUTATION (INDIGO): UPDATED EFFICACY RESULTS. Neuro-Oncology Advances. 6(Supplement_4). iv9–iv9.
2.
Mellinghoff, Ingo K., Patrick Y. Wen, Jennie Taylor, et al.. (2024). CTNI-47. A PHASE 1, RANDOMIZED, PERIOPERATIVE TRIAL OF VORASIDENIB AND IVOSIDENIB IN IDH1-MUTANT DIFFUSE GLIOMA: UPDATED RESULTS. Neuro-Oncology. 26(Supplement_8). viii107–viii107.
3.
Mellinghoff, Ingo K., Martin J. van den Bent, Deborah T. Blumenthal, et al.. (2023). KS02.6.A INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE III STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH RESIDUAL OR RECURRENT GRADE 2 GLIOMA WITH AN IDH1/2 MUTATION. Neuro-Oncology. 25(Supplement_2). ii4–ii5.
4.
Blumenthal, Deborah T., Ingo K. Mellinghoff, Martin J. van den Bent, et al.. (2023). 498O INDIGO: A randomized, double-blinded, phase III study of vorasidenib versus placebo in IDH1 or IDH2 low-grade glioma. Annals of Oncology. 34. S391–S391.
5.
Mellinghoff, Ingo K., Min Lu, Patrick Y. Wen, et al.. (2023). Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. Nature Medicine. 29(3). 615–622.
6.
Mellinghoff, Ingo K., Martin J. van den Bent, Jennifer Clarke, et al.. (2020). RTID-05. INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF VORASIDENIB (AG-881) VS PLACEBO IN PATIENTS WITH RESIDUAL/RECURRENT GRADE II GLIOMA WITH AN ISOCITRATE DEHYDROGENASE 1/2 (IDH1/2) MUTATION. Neuro-Oncology. 22(Supplement_2). ii194–ii194.
7.
Mellinghoff, Ingo K., Martin J. van den Bent, Jennifer Clarke, et al.. (2020). INDIGO: A global, randomized, double-blind, phase III study of vorasidenib (VOR; AG-881) vs placebo in patients (pts) with residual or recurrent grade II glioma with an isocitrate dehydrogenase 1/2 (IDH1/2) mutation.. Journal of Clinical Oncology. 38(15_suppl). TPS2574–TPS2574.
8.
Tran, Hai T., Vincent K. Lam, Lingzhi Hong, et al.. (2019). P1.01-98 Outcomes in Advanced NSCLC Patients Treated with 1st Line EGFR-TKI Based on Mutation Detection from Tissue or cfDNA-Based Genomic Sequencing. Journal of Thoracic Oncology. 14(10). S399–S400.
9.
Elshafeey, Nabil, Aikaterini Kotrotsou, Islam Hassan, et al.. (2019). Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. Nature Communications. 10(1). 3170–3170.
10.
Vedantam, Aditya, Islam Hassan, Aikaterini Kotrotsou, et al.. (2019). Magnetic Resonance-Based Radiomic Analysis of Radiofrequency Lesion Predicts Outcomes After Percutaneous Cordotomy: A Feasibility Study. Operative Neurosurgery. 18(6). 721–727.
11.
Zinn, Pascal O., Sanjay K. Singh, Aikaterini Kotrotsou, et al.. (2018). A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models. Clinical Cancer Research. 24(24). 6288–6299.
12.
Hassan, Islam, Ping Hou, Guang Li, et al.. (2018). Comparison of functional localization accuracy with different co‐registration strategies in presurgical fMRI for brain tumor patients. Medical Physics. 45(7). 3223–3228.
13.
Zinn, Pascal O., Sanjay K. Singh, Aikaterini Kotrotsou, et al.. (2017). Distinct Radiomic Phenotypes Define Glioblastoma TP53-PTEN-EGFR Mutational Landscape. Neurosurgery. 64(CN_suppl_1). 203–210.
14.
Elshafeey, Nabil, Islam Hassan, Pascal O. Zinn, & Rivka R. Colen. (2017). From K-space to Nucleotide. Topics in Magnetic Resonance Imaging. 26(1). 33–41.
15.
Hassan, Islam, Aikaterini Kotrotsou, Srishti Abrol, et al.. (2017). Silent Sentence Completion Shows Superiority Localizing Wernicke’s Area and Activation Patterns of Distinct Language Paradigms Correlate with Genomics: Prospective Study. Scientific Reports. 7(1). 12054–12054.
16.
Hassan, Islam, Aikaterini Kotrotsou, Kristin Alfaro-Munoz, et al.. (2017). NIMG-28. INCREASED MUTATION BURDEN (HYPERMUTATION) IN GLIOMAS IS ASSOCIATED WITH A UNIQUE RADIOMIC TEXTURE SIGNATURE IN MAGNETIC RESONANCE IMAGING. Neuro-Oncology. 19(suppl_6). vi147–vi148.
17.
Colen, Rivka R., Islam Hassan, Nabil Elshafeey, & Pascal O. Zinn. (2016). Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics. Magnetic Resonance Imaging Clinics of North America. 24(4). 741–749.
18.
Hassan, Islam, Aikaterini Kotrotsou, Ali Bakhtiari, et al.. (2016). Radiomic Texture Analysis Mapping Predicts Areas of True Functional MRI Activity. Scientific Reports. 6(1). 25295–25295.
19.
Hassan, Islam, et al.. (2013). The Neuropsychiatry of Hyperkinetic Movement Disorders: Insights from Neuroimaging into the Neural Circuit Bases of Dysfunction. SHILAP Revista de lepidopterología. 3.
20.
Shehu, B. B. & Islam Hassan. (2009). Cervicothoracic arachnoid scys in a patient with neurofibromatosis: Case report. East African Medical Journal. 83(9). 515–7.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Bethania Fernandes Breakdown of academic impact, for papers by Abudumijiti Aibaidula Breakdown of academic impact, for papers by Jan‐Michael Werner Breakdown of academic impact, for papers by Mart A. A. M. Heesters Breakdown of academic impact, for papers by Thomas Urup Breakdown of academic impact, for papers by Baoshi Chen Breakdown of academic impact, for papers by Kirsten Grunnet Breakdown of academic impact, for papers by Annekathrin Kratz Breakdown of academic impact, for papers by Marta Padovan Breakdown of academic impact, for papers by Christine Jungk